The Brüstle-Patent-Case – Legal Background and Impacts to European Stem Cell Research and International Cooperation
Timo Faltus, University of Leipzig, speaking at Stem Cells & Bioprocessing Europe 2012.
Drug Discovery Technology using Human iPS Cells
Dr. Chikafumi Yokoyama, ReproCELL Inc., speaking at Stem Cells 2012
How to Improve Interoperability of biobanks: European and International Initiatives
Kurt Zatloukal, Medical University of Graz, speaking at European Lab Automation 2012
Gene-modified MSCs for Chronic Stroke: Why Choose Brain Surgery?
Dr Casey Case, SanBio, speaking at Stem Cells 2012.
Understanding Cell Transitions at Single-Cell Level
Dr Anders Ståhlberg, University of Gothenburg in Sweden, speaking at Single Cell Analysis Europe 2012.
The Influence of Structures on Cellular Processes During Differentiation of neuronal Stem Cells - Adhesion
Clemens Holzer, Medical University Graz, speaking at Cell Culture 2012
Double Blinded Drug Discovery (DBD2): A New Protected Open Innovation Model
Melvin Reichman, LIMR Chemical Genomics Center, speaking at European Lab Automation 2012
Challenges for Stem Cell Bioprocessing - Scale-Up or Scale-Out?
Christopher Hewitt, Loughborough University, speaking at Cell Culture 2012
Regulation of Cytochrome P450s and Nuclear Receptor by microRNAs and its Toxicological Implications
Tsuyoshi Yokoi, Kanazawa University, speaking at ADME & Predictive Toxicology Europe